Certara to Host Inaugural Symposium Dedicated to Advancing Pediatric Drug Development

Princeton, N.J., August 4, 2021: Certara, the global leader in biosimulation, today announced it will host the inaugural New Horizons in Pediatric Drug Development Symposium taking place October 28-29, 2021. The two-day virtual symposium is being held to bring together thought leaders and innovators in pediatric drug development to share new developments in the field … Continued

Mubadala Invests in Global Biosimulation Leader Certara

Princeton, N.J., July 27, 2021: Certara (NASDAQ: CERT), a global leader in biosimulation, today announced that Mubadala Investment Company (Mubadala) has made an approximately $250 million investment in Certara.  The investment aligns with Mubadala’s strategy of enabling innovation to address unmet clinical needs and drive cost efficiencies. Mubadala and certain existing institutional shareholders of Certara, including … Continued

Certara’s Vaccine Simulator™ Accurately Predicted Optimal Timing Between Doses for COVID-19

Clinical Study Confirms Quantitative Systems Pharmacology (QSP) Prediction, Showcasing the Power of Biosimulation Technology Princeton, N.J., July 23, 2021: Certara, a global leader in biosimulation, today announced that its Vaccine Simulator accurately predicted that eight weeks was the optimal timing between the first and second dose of COVID-19 vaccines. The Pitch study conducted at Oxford … Continued

Certara Announces New Chief Human Resources Officer

Veteran HR leader brings 20+ years of human resources experience to the company’s executive team PRINCETON, N.J.— July 13, 2021. Certara®, a global leader in biosimulation, today announced that it has appointed Nicolette D. Sherman to the position of Chief Human Resources Officer (CHRO). Sherman joins Certara with extensive experience in the biopharmaceutical industry, leading … Continued

Certara Announces Update of BaseCase Software, the Company’s Value Communication Platform

Major Release to Help Life Science Companies Maximize Go-to-Market Impact Princeton, N.J., July 8, 2021. Certara, a global leader in biosimulation, today announced the release of BaseCase software version 2021.06, which updates the value communication software platform to include new capabilities that can provide biopharmaceutical and medical device companies greater commercial success for new therapies … Continued

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions

The PMDA enters 8th consecutive year of using Certara’s biosimulation software PRINCETON, N.J.—June 23, 2021. Certara, a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has renewed its licenses of Certara’s Simcyp™ and Phoenix™ biosimulation software. The PMDA has been using Certara’s biosimulation software since 2014. The Simcyp … Continued

Certara Appoints Dr. Carol Gallagher as New Independent Board Member

Dr. Gallagher brings more than 30 years of drug development and commercial leadership experience to her new role PRINCETON, N.J.—June 14, 2021.  Certara, a global leader in biosimulation, today announced the addition of Carol Gallagher, Pharm.D., to its board of directors.  Dr. Gallagher is an experienced biopharmaceutical director and operator and serves as a venture … Continued

1 of 26
Back to top
Powered by Translations.com GlobalLink OneLink Software